Our previous work revealed that circulating levels of IL-1β and IL-6 are elevated in a subset of CLL patients and that these two cytokines belong to a cluster of cytokines whose presence correlates with longer TTFT and overall survival in the CLL patient population [26]. This evidence concerns the gene IL1B and B-cell chronic lymphocytic leukemia.